Biblio
Found 95 results
[ Author] Keyword Title Type Year Filters: Keyword is Alzheimer Disease [Clear All Filters]
“Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants.”, PLoS Genet, vol. 8, no. 6, p. e1002707, 2012.
, “Lack of genetic association of cholesteryl ester transfer protein polymorphisms with late onset Alzheimers disease.”, Neurosci Lett, vol. 381, no. 1-2, pp. 36-41, 2005.
, “Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease.”, Cell, vol. 153, no. 3, pp. 707-20, 2013.
, “Differences in apolipoprotein E3/3 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease.”, Neurobiol Dis, vol. 21, no. 2, pp. 256-75, 2006.
, “Genetic control of human brain transcript expression in Alzheimer disease.”, Am J Hum Genet, vol. 84, no. 4, pp. 445-58, 2009.
, “The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer's disease.”, Sci Data, vol. 5, p. 180185, 2018.
, “Analysis of European mitochondrial haplogroups with Alzheimer disease risk.”, Neurosci Lett, vol. 365, no. 1, pp. 28-32, 2004.
, “Lewy body pathology is a frequent co-pathology in familial Alzheimer's disease.”, Acta Neuropathol, vol. 105, no. 5, pp. 484-8, 2003.
, “Alzheimer's disease risk genes and the age-at-onset phenotype.”, Neurobiol Aging, vol. 34, no. 11, pp. 2696.e1-5, 2013.
, “Analysis of copy number variation in Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.”, PLoS One, vol. 7, no. 12, p. e50640, 2012.
, “Ubiquilin 1 polymorphisms are not associated with late-onset Alzheimer's disease.”, Ann Neurol, vol. 59, no. 1, pp. 21-6, 2006.
, “The ubiquilin 1 gene and Alzheimer's disease.”, N Engl J Med, vol. 352, no. 26, pp. 2752-3; author reply 2752-3, 2005.
, “Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.”, Nat Genet, vol. 49, no. 9, pp. 1373-1384, 2017.
, “Defining the Genetic Architecture of Alzheimer's Disease: Where Next.”, Neurodegener Dis, vol. 16, no. 1-2, pp. 6-11, 2016.
, “Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22.”, Am J Hum Genet, vol. 73, no. 5, pp. 1041-51, 2003.
, “Rarity of the Alzheimer disease-protective APP A673T variant in the United States.”, JAMA Neurol, vol. 72, no. 2, pp. 209-16, 2015.
, “Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms.”, Nature, vol. 429, no. 6987, pp. 75-9, 2004.
, “Alzheimer's disease: analyzing the missing heritability.”, PLoS One, vol. 8, no. 11, p. e79771, 2013.
, “Analysis of lipid pathway genes indicates association of sequence variation near SREBF1/TOM1L2/ATPAF2 with dementia risk.”, Hum Mol Genet, vol. 19, no. 10, pp. 2068-78, 2010.
, “Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans.”, JAMA, vol. 309, no. 14, pp. 1483-92, 2013.
, “Genetic diagnosis and prognosis of Alzheimer's disease: challenges and opportunities.”, Expert Rev Mol Diagn, vol. 15, no. 3, pp. 339-48, 2015.
, “Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP).”, Transl Psychiatry, vol. 3, p. e256, 2013.
, “GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.”, Neuron, vol. 54, no. 5, pp. 713-20, 2007.
, ,
“Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.”, Am J Epidemiol, vol. 146, no. 5, pp. 373-84, 1997.
,